Microvolt T-wave Alternans in Cardiac Surgery Patients

The purpose of this study is to measure MTWA in the patients undergoing cardiac surgery and to investigate the relation between MTWA and adverse clinical outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Complications Electrocardiogram: Electrical Alternans Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Hospital

Seoul, 03080, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients underwent cardiac surgery including coronary artery bypass graft surgery with or without cardiopulmonary bypass, cardiac valve surgery, cardiac mass excision, thoracic aorta surgery, etc.

Exclusion criteria

unavailability of the recording equipment

Treatment and study plan

Primary outcomes

in hospital mortality

Time frame: up to 3 months(during hospital stay)

in hospital death

Secondary outcomes

postoperative complication

Time frame: up to 3 months(during hospital stay)

The secondary end points were myocardial infarction, ventricular tachycardia, atrial fibrillation, cardiogenic shock, stroke, coma, renal failure, respiratory failure, and length of stay in intensive care unit (ICU) and hospital.

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Important dates

Study start: 2013
Primary completion: 2016
Study completion: 2016
First posted: Jun 28, 2017
Registry last updated: Jun 28, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed